白消安、氟达拉滨和环磷酰胺（BFC）预处理方案使肾上腺脑白质营养不良和黏多糖贮积症患儿在单倍体相合异基因干细胞移植后实现了稳定植入。 - Suppr

Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis.

作者信息

Chen Yao, Xu Lan-Ping, Zhang Xiao-Hui, Chen Huan, Wang Feng-Rong, Liu Kai-Yan, Qin Jiong, Yang Yan-Ling, Huang Xiao-Jun

机构信息

Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.

Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Diseases, Beijing, China.

出版信息

Bone Marrow Transplant. 2018 Jun;53(6):770-773. doi: 10.1038/s41409-018-0175-8. Epub 2018 May 3.

DOI:10.1038/s41409-018-0175-8

PMID:29725109

Abstract

摘要

相似文献

Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis.

Bone Marrow Transplant. 2018 Jun;53(6):770-773. doi: 10.1038/s41409-018-0175-8. Epub 2018 May 3.

Non-myeloablative conditioning regimen of fludarabine, busulfan, anti-thymocyte globulin, and methylprednisolone for allogeneic peripheral blood hematopoietic cell transplantation.

Haematologica. 2001 Sep;86(9):999-1001.

Comparison of Different Conditioning Regimens of Haploidentical Hematopoietic Stem Cell Transplant in Patients With Acute Myeloid Leukemia.

Exp Clin Transplant. 2018 Dec;16(6):736-744. doi: 10.6002/ect.2017.0100. Epub 2018 May 23.

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan.

Leukemia. 2007 Oct;21(10):2109-16. doi: 10.1038/sj.leu.2404886. Epub 2007 Aug 9.

Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation.

Bone Marrow Transplant. 2006 Oct;38(7):477-82. doi: 10.1038/sj.bmt.1705480.

Posttransplant Cyclophosphamide for HLA-haploidentical Transplantation in Patients With Mucopolysaccharidosis.

J Pediatr Hematol Oncol. 2018 Aug;40(6):e350-e354. doi: 10.1097/MPH.0000000000001157.

[A comparison of toxicity and efficacy between busulfan plus fludarabine and busulfan plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia].

Zhonghua Nei Ke Za Zhi. 2012 Nov;51(11):880-4.

Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.

Bone Marrow Transplant. 2007 Feb;39(4):193-9. doi: 10.1038/sj.bmt.1705556. Epub 2007 Jan 15.

A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies.

Oncotarget. 2016 Nov 29;7(48):78773-78786. doi: 10.18632/oncotarget.12383.

New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.

Bone Marrow Transplant. 2007 Sep;40(6):541-7. doi: 10.1038/sj.bmt.1705770. Epub 2007 Jul 16.

引用本文的文献

Optimization of T-cell-replete haploidentical hematopoietic stem cell transplantation: the Chinese experience.

Haematologica. 2025 Mar 1;110(3):562-575. doi: 10.3324/haematol.2024.286194.

Current Concepts in the Management of Sanfilippo Syndrome (MPS III): A Narrative Review.

Cureus. 2024 Apr 11;16(4):e58023. doi: 10.7759/cureus.58023. eCollection 2024 Apr.

External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients.

Front Pharmacol. 2022 Jul 7;13:835037. doi: 10.3389/fphar.2022.835037. eCollection 2022.

Current status and prospects of hematopoietic stem cell transplantation in China.

Chin Med J (Engl). 2022 Jun 20;135(12):1394-1403. doi: 10.1097/CM9.0000000000002235.

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.

J Hematol Oncol. 2021 Sep 15;14(1):145. doi: 10.1186/s13045-021-01159-2.

Considerations in Preparative Regimen Selection to Minimize Rejection in Pediatric Hematopoietic Transplantation in Non-Malignant Diseases.

Front Immunol. 2020 Oct 19;11:567423. doi: 10.3389/fimmu.2020.567423. eCollection 2020.

A Cure for Sanfilippo Syndrome? A Summary of Current Therapeutic Approaches and their Promise.

Med Res Arch. 2020 Feb 1;8(2). doi: 10.18103/mra.v8i2.2045. Epub 2020 Feb 21.

Granulocyte Colony-Stimulating Factor-Primed Unmanipulated Haploidentical Blood and Marrow Transplantation.

Front Immunol. 2019 Nov 1;10:2516. doi: 10.3389/fimmu.2019.02516. eCollection 2019.

Update of the "Beijing Protocol" haplo-identical hematopoietic stem cell transplantation.

Bone Marrow Transplant. 2019 Aug;54(Suppl 2):703-707. doi: 10.1038/s41409-019-0605-2.

Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments.

Drugs. 2019 Jul;79(10):1103-1134. doi: 10.1007/s40265-019-01147-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献